BeStock  
Stocks › Medical Devices › GMED

Globus Medical GMED

US equityMarket cap rank #1513Medical Devices
$66.89 −$1.71 (-2.49%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $66.89 0.00%
Open$68.44
Prev close$68.60
Day range$66.63 – $69.54
Volume1.51M
Market cap$8.86B
P/E (TTM)16.5
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$763.72M-0.7% YoY
Operating profit$178.23M+32.0% YoY
Net profit$141.17M+18.7% YoY
Diluted EPS$1.04+18.2% YoY
Free cash flow$224.84M+5.1% YoY
Operating cash flow$265.23M

Revenue, last 8 quarters

$657.3MDec '24$598.1MMar '25$745.3MJun '25$769.0MSep '25$826.4MDec '25$759.9MMar '26$789.6MJun '26$763.7MSep '26

Net profit, last 8 quarters

$26.5MDec '24$75.5MMar '25$202.8MJun '25$119.0MSep '25$140.6MDec '25$124.3MMar '26$151.6MJun '26$141.2MSep '26

Diluted EPS by quarter

0.19Dec '240.54Mar '251.49Jun '250.88Sep '251.03Dec '250.90Mar '261.10Jun '261.04Sep '26

Free cash flow by quarter

$193.2MDec '24$141.2MMar '25$31.3MJun '25$213.9MSep '25$192.6MDec '25$162.7MMar '26$176.6MJun '26$224.8MSep '26

Annual revenue

$789.0MFY20$958.1MFY21$1.0BFY22$1.6BFY23$2.5BFY24$2.9BFY25

Profitability & balance sheet

Gross margin69.1%
Operating margin22.8%
Net margin17.8%
Return on equity12.1%
Return on assets10.5%
Return on invested capital11.8%
Current ratio4.30
Liabilities / assets13.2%
Cash & investments$517.44M
Total debt$93.38M
Net cash (debt)$424.06M
Free cash flow / sales24.1%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Musculoskeletal Solutions$728.86M 95.4%
  • Enabling Technologies$34.86M 4.6%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $763.72M $789.61M $759.85M $2.94B $826.42M
Total Operating Revenue $763.72M $789.61M $759.85M $2.94B $826.42M
Cost of Revenue $232.92M $241.44M $234.07M $957.80M $261.11M
Gross Profit $530.80M $548.17M $525.79M $1.98B $565.31M
Operating Expense $352.57M $352.70M $363.81M $1.44B $384.00M
Selling and Admin Expenses $288.47M $286.82M $297.78M $1.18B $318.48M
Research & Development $34.53M $36.32M $36.51M $147.25M $36.16M
Depreciation & Amortization & Depletion $29.57M $29.56M $29.53M $118.19M $29.36M
-Depreciation & Amortization $29.57M $29.56M $29.53M $118.19M $29.36M
Operating Profit $178.23M $195.47M $161.98M $537.19M $181.31M
Net Non-Operating Interest Income (Expense) $8.41M $7.07M $5.43M $7.14M $3.31M
Total Other Finance Costs -$8.41M -$7.07M -$5.43M -$7.14M -$3.31M
Other Income (Expense) -$3.37M -$12.73M -$10.34M $60.74M -$15.39M
Gain on Sale of Security -$1.71M -$860,000.00 -$2.11M -$3.01M -$7.15M
Special Income (Charges) -$677,000.00 -$13.04M -$10.47M $60.33M -$8.63M
-Less:Restructuring and Mergern & Acquisition $677,000.00 $13.04M $10.47M -$60.33M $8.63M
Other Non-Operating Income (Expenses) -$982,000.00 $1.17M $2.25M $3.41M $391,000.00
Pretax Profit $183.27M $189.82M $157.07M $605.07M $169.23M
Tax $42.10M $38.25M $32.77M $67.20M $28.64M
Net Profit $141.17M $151.57M $124.30M $537.87M $140.59M
Profit from Continuing Operations $141.17M $151.57M $124.30M $537.87M $140.59M
Net Income to Parent Company $141.17M $151.57M $124.30M $537.87M $140.59M
Net Income to Common Stockholders $141.17M $151.57M $124.30M $537.87M $140.59M
Basic EPS $1.05 $1.12 $0.92 $3.98 $1.05
Diluted EPS $1.04 $1.10 $0.90 $3.92 $1.03

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $5.53B $5.49B $5.44B $5.30B $5.30B
Total Current Assets $2.18B $2.22B $2.20B $2.13B $2.13B
Cash and Cash Equivalents & Short-Term Investments $517.44M $595.14M $629.85M $557.24M $557.24M
-Cash and Cash Equivalents $441.27M $507.75M $560.95M $526.16M $526.16M
-Short Term Investments $76.16M $87.40M $68.90M $31.09M $31.09M
Receivables $723.95M $739.28M $735.44M $743.67M $743.67M
-Accounts Receivable $675.30M $692.18M $686.43M $678.94M $678.94M
-Taxes Receivable $48.65M $47.10M $49.01M $64.73M $64.73M
Inventory $824.14M $810.90M $772.60M $759.28M $759.28M
Other Current Assets $116.44M $70.20M $60.23M $65.43M $65.43M
Total Non-Current Assets $3.35B $3.27B $3.24B $3.18B $3.18B
Net PPE $589.53M $592.68M $618.65M $628.24M $628.24M
-Gross PPE $1.40B $1.36B $1.37B $1.33B $1.33B
-Accumulated Depreciation -$808.87M -$770.09M -$747.58M -$705.00M -$705.00M
Investments and Advances $353.74M $245.36M $169.44M $71.82M $71.82M
-Available for Sale Securities $175.08M $140.82M $89.44M $34.96M $34.96M
-Held to Maturity Securities $178.66M $104.54M $80.00M $36.86M $36.86M
Goodwill and Other Intangible Assets $2.12B $2.13B $2.16B $2.18B $2.18B
-Goodwill $1.45B $1.44B $1.44B $1.44B $1.44B
-Other Intangible Assets $667.47M $692.62M $720.85M $745.06M $745.06M
Non-Current Deferred Assets $205.94M $224.63M $214.81M $218.22M $218.22M
Other Non-Current Assets $75.99M $79.24M $78.96M $78.78M $78.78M
Total Liabilities $731.94M $719.66M $707.24M $729.51M $729.51M
Total Current Liabilities $507.94M $479.35M $482.46M $498.50M $498.50M
Payables $140.39M $141.84M $135.83M $132.25M $132.25M
-Accounts Payable $107.43M $106.94M $103.66M $98.85M $98.85M
-Total Tax Payable $32.97M $34.90M $32.17M $33.40M $33.40M
Current Accrued Expenses $142.80M $133.63M $137.99M $137.24M $137.24M
Short-Term Debt and Capital Lease Obligation $14.18M $14.39M $15.12M $14.74M $14.74M
-Current Capital Lease Obligation $14.18M $14.39M $15.12M $14.74M $14.74M
Current Deferred Liabilities $27.81M $27.98M $26.35M $27.66M $27.66M
Other Current Liabilities $25.82M $23.28M $20.87M $19.51M $19.51M
Total Non-Current Liabilities $224.01M $240.31M $224.78M $231.01M $231.01M
Long Term Debt and Capital Lease Obligation $93.38M $96.81M $100.10M $103.92M $103.92M
-Long Term Capital Lease Obligation $93.38M $96.81M $100.10M $103.92M $103.92M
Non-Current Deferred Liabilities $31.60M $42.34M $24.66M $23.76M $23.76M
Other Non-Current Liabilities $99.02M $101.16M $100.02M $103.34M $103.34M
Total Equity $4.80B $4.77B $4.73B $4.57B $4.57B
Stockholders' Equity $4.80B $4.77B $4.73B $4.57B $4.57B
Capital Stock $132,000.00 $134,000.00 $135,000.00 $135,000.00 $135,000.00
-Common Stock $132,000.00 $134,000.00 $135,000.00 $135,000.00 $135,000.00
Additional Paid-In Capital $3.26B $3.23B $3.21B $3.17B $3.17B
Retained Earnings $1.53B $1.53B $1.51B $1.39B $1.39B
Gains/Losses Not Affecting Retained Earnings $11.34M $11.20M $14.40M $15.35M $15.35M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $265.23M $209.74M $202.36M $753.45M $248.59M
Net cash flow from continuing operations $265.23M $209.74M $202.36M $753.45M $248.59M
Net Income from Continuing Operations $141.17M $151.57M $124.30M $537.87M $140.59M
Gain/Loss from Continuing Operations $1.27M $3.23M $2.55M -$66,000.00 $6.12M
Depreciation & Depletion & Amortization $70.38M $69.50M $69.86M $276.84M $69.49M
Deferred Tax $9.03M $7.79M $7.96M $18.63M $18.10M
Other Non-Cash Items -$197,000.00 $9.38M $2.96M -$95.15M $13.34M
Change in Working Capital $23.41M -$55.07M -$28.12M -$66.80M -$21.51M
-Change in Receivables $14.87M -$13.81M -$13.40M -$52.18M -$64.15M
-Change in Inventory -$15.54M -$27.90M -$16.65M -$17.60M -$178,000.00
-Change in Prepaid Assets $4.29M -$7.40M $6.94M $11.13M $17.82M
-Change in Payables and Accrued Expense $21.64M -$10.76M -$19.59M $42.70M $17.92M
-Change In Other Working Capital -$1.85M $4.81M $14.58M -$50.85M $7.09M
Net cash flow from investing -$155.90M -$129.05M -$182.67M -$355.01M -$111.45M
Net Cash Flow from Continuing Investing Activities -$155.90M -$129.05M -$182.67M -$355.01M -$111.45M
Net PPE Purchase and Sale -$40.39M -$33.17M -$39.62M -$164.68M -$46.20M
Net Business Purchase and Sale -$16.01M -$1.50M -$4.91M -$252.55M $9.67M
Net Investment Purchase and Sale -$99.51M -$94.38M -$138.15M $71.96M -$65.17M
Financing Cash Flow -$130.76M -$134.50M $18.20M -$679.16M $13.22M
Net Cash Flow from Continuing Financing Activities -$130.76M -$134.50M $18.20M -$679.16M $13.22M
Net Issuance Payments Of Debt $0.00 $0.00 $0.00 -$449.99M $0.00
Net Common Stock Issuance -$142.94M -$136.06M $0.00 -$300.45M -$45.00M
Proceeds from Stock Option Exercised $15.88M $10.97M $25.96M $89.76M $62.76M
Net Other Financing Charges -$3.70M -$9.41M -$7.76M -$18.48M -$4.54M
Ending Cash Balance $487.69M $507.75M $560.95M $526.16M $526.16M
Net Change in Cash -$21.44M -$53.80M $37.89M -$280.73M $150.35M
Beginning Cash Balance $507.75M $560.95M $526.16M $784.44M $371.77M
Effect of Exchange Rate Changes $1.38M $598,000.00 -$3.09M $22.45M $4.03M
Free Cash Flow $224.84M $176.57M $162.75M $579.02M $192.64M
Net Intangibles Purchase and Sale – – – -$9.75M -$80,000.00

Discussion

No comments yet — be the first to weigh in on GMED.

Sign in to join the discussion.

Scroll to Top